SCHEMBL23348261

SCHEMBL23348261

Cc1cc2c3ccc4ccccc4c3n(-c3ccccc3)c2c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.42
CYP2A6 P11509 3/20 0.42
MAPT P10636 3/20 0.41
ATM Q13315 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 3/20 0.41
KMT2A Q03164 2/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 4/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ACHE P22303 1/20 0.38
SLC6A2 P23975 1/20 0.38
AHR P35869 1/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18803892 0.87 MYC (0.36) CYP1A2CYP2A6MAPTATML3MBTL1
SCHEMBL10061174 0.86 HPRT1 (0.48) CYP1A2CYP2A6MAPTATML3MBTL1
SCHEMBL16905881 0.85 CYP2A6 (0.47) CYP1A2CYP2A6MAPTATML3MBTL1
SCHEMBL26342558 0.82 CYP1A2 (0.38) CYP1A2CYP2A6MAPTATML3MBTL1
SCHEMBL18803913 0.81 CYP1A2 (0.42) CYP1A2CYP2A6MAPTKDM4EKMT2A
SCHEMBL23348074 0.81 KDM4E (0.41) CYP1A2CYP2A6MAPTATML3MBTL1
SCHEMBL19849880 0.81 KDM4E (0.42) CYP1A2CYP2A6MAPTATML3MBTL1
SCHEMBL17486941 0.80 HPRT1 (0.50) CYP1A2CYP2A6ATML3MBTL1KDM4E
SCHEMBL18069049 0.80 KDM4E (0.57) CYP1A2MAPTATML3MBTL1KDM4E
SCHEMBL23348259 0.79 KDM4E (0.42) CYP1A2CYP2A6MAPTATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139445-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, Display Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139445-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, Display Device, and Lighting Device DDT, SLC43A1, SLCO2A1 CYP1A2 209/4885CYP2A6 417/4885MAPT 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.